ClinicalTrials.Veeva

Menu

A Study to Investigate the Safety and Effectiveness of Aspheric Laser Refractive Surgery Treatments for Myopia

Bausch + Lomb logo

Bausch + Lomb

Status

Completed

Conditions

Myopia
Astigmatism

Treatments

Device: The Bausch & Lomb Zyoptix Tissue Saving Aspheric algorithm
Device: The Bausch & Lomb Zyoptix Tissue Saving algorithm

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

The objective of this study was to compare the safety and effectiveness of two versions of the Bausch & Lomb Zyoptix Tissue Saving Aspheric Algorithm versus the current Zyoptix Tissue Saving Algorithm when used for myopia and myopic astigmatism LASIK treatment.

Enrollment

127 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Myopia with or without astigmatism.
  • Normal Corneal topography
  • Willing to have both eyes treated with the laser.

Exclusion criteria

  • Contraindications to LASIK.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

127 participants in 2 patient groups

Zyoptix Tissue Saving Aspheric
Experimental group
Description:
The Bausch \& Lomb Zyoptix Tissue Saving Aspheric algorithm is used for treatment with LASIK for the correction of myopia and myopic astigmatism.
Treatment:
Device: The Bausch & Lomb Zyoptix Tissue Saving Aspheric algorithm
Zyoptix Tissue Saving
Active Comparator group
Description:
The Bausch \& Lomb Zyoptix Tissue Saving algorithm is used for treatment with LASIK for the correction of myopia and myopic astigmatism.
Treatment:
Device: The Bausch & Lomb Zyoptix Tissue Saving algorithm

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems